Business Standard

Astrazeneca Pharma India & Dr Reddys Laboratories enter into distribution agreement

Image

Capital Market
Astrazeneca Pharma India and Dr Reddys Laboratories announced that they have entered into a distribution agreement for Riax, a new brand of saxagliptin and Riax-M a fixed dose combination of saxagliptin with metformin. Both Riax and Riax M are trademarks of the AstraZeneca group. AZPIL already has two brands under the trademark Onglyza and Kombiglyze for saxagliptin and in fixed dose combination with metformin respectively, promoted and distributed in the Indian market.

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 29 2015 | 7:27 PM IST

Explore News